128 related articles for article (PubMed ID: 2669801)
21. Prevention of acute rejection episodes with an anti-interleukin 2 receptor monoclonal antibody. II. Results after a second kidney transplantation.
Hourmant M; Le Mauff B; Cantarovich D; Dantal J; Baatard R; Denis M; Jacques Y; Karam G; Soulillou JP
Transplantation; 1994 Jan; 57(2):204-7. PubMed ID: 8310508
[TBL] [Abstract][Full Text] [Related]
22. Impacts of low-dose steroids and prophylactic monoclonal versus polyclonal antibodies on acute rejection in cyclosporine- and azathioprine-immunosuppressed cardiac allografts.
Laufer G; Laczkovics A; Wollenek G; Schreiner W; Sochor H; Holzinger C; Buchelt M; Fasol R; Wolner E
J Heart Transplant; 1989; 8(3):253-61. PubMed ID: 2661776
[TBL] [Abstract][Full Text] [Related]
23. Randomized clinical trial of antithymocyte globulin in cadaver renal allograft recipients: importance of T cell monitoring.
Cosimi AB; Wortis HH; Delmonico FL; Russell PS
Surgery; 1976 Aug; 80(2):155-63. PubMed ID: 781887
[TBL] [Abstract][Full Text] [Related]
24. Sequential biological immunosuppression. Induction therapy with rabbit antithymocyte globulin.
Guttmann RD; Flemming C
Clin Transplant; 1997 Jun; 11(3):185-92. PubMed ID: 9193840
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of OKT3 monoclonal antibody and anti-thymocyte globulin in the treatment of steroid-resistant acute allograft rejection in pediatric renal transplants.
Mochon M; Kaiser B; Palmer JA; Polinsky M; Flynn JT; Caputo GC; Baluarte HJ
Pediatr Nephrol; 1993 Jun; 7(3):259-62. PubMed ID: 8518094
[TBL] [Abstract][Full Text] [Related]
26. Rabbit-ATG or basiliximab induction for rapid steroid withdrawal after renal transplantation (Harmony): an open-label, multicentre, randomised controlled trial.
Thomusch O; Wiesener M; Opgenoorth M; Pascher A; Woitas RP; Witzke O; Jaenigen B; Rentsch M; Wolters H; Rath T; Cingöz T; Benck U; Banas B; Hugo C
Lancet; 2016 Dec; 388(10063):3006-3016. PubMed ID: 27871759
[TBL] [Abstract][Full Text] [Related]
27. Antithymocyte globulin in cadaver renal grafts: prophylaxis and antirejection therapy with three different preparations.
MacDonald AS; Belitsky P; Lannon SG; Cohen A; White J
Transplant Proc; 1982 Dec; 14(4):631-4. PubMed ID: 6762719
[TBL] [Abstract][Full Text] [Related]
28. Selective conversion from azathioprine to cyclosporin for steroid-resistant rejection in renal transplants: an alternative therapy.
Crowson MC; Berisa F; McGonigle RJ; Adu D; Michael J; Barnes AD
Nephrol Dial Transplant; 1989; 4(2):129-32. PubMed ID: 2496354
[TBL] [Abstract][Full Text] [Related]
29. Individualized T cell monitored administration of ATG versus OKT3 in steroid-resistant kidney graft rejection.
Midtvedt K; Fauchald P; Lien B; Hartmann A; Albrechtsen D; Bjerkely BL; Leivestad T; Brekke IB
Clin Transplant; 2003 Feb; 17(1):69-74. PubMed ID: 12588325
[TBL] [Abstract][Full Text] [Related]
30. Administration of ATG according to the absolute T lymphocyte count during therapy for steroid-resistant rejection.
Clark KR; Forsythe JL; Shenton BK; Lennard TW; Proud G; Taylor RM
Transpl Int; 1993 Jan; 6(1):18-21. PubMed ID: 8383974
[TBL] [Abstract][Full Text] [Related]
31. Improved graft prognosis by treatment of steroid resistant rejections with ATG and plasmapheresis.
Fassbinder W; Scheuermann EH; Stutte HJ; Bechstein PB; Fürsch A; Ernst W; Schoeppe W
Proc Eur Dial Transplant Assoc; 1983; 20():362-7. PubMed ID: 6361750
[TBL] [Abstract][Full Text] [Related]
32. Comparison of kidney transplant survival between patients treated with cyclosporine and those treated with azathioprine and antithymocyte globulin.
Cho SI; Bradley JW; Monaco AP; Tilney NL
Am J Surg; 1984 Apr; 147(4):518-23. PubMed ID: 6370008
[TBL] [Abstract][Full Text] [Related]
33. Reversal of steroid- and antithymocyte globulin-resistant acute rejection crises in renal transplantation with monoclonal antibody (OKT3).
Prieto C; Rodriguez-Paternina E; Andrés A; Morales JM; Farias J; Montoyo C; Regueiro JR; Rodicio JL
Transplant Proc; 1990 Aug; 22(4):1753-4. PubMed ID: 2117798
[No Abstract] [Full Text] [Related]
34. Prophylaxis of heart transplant rejection with either antithymocyte globulin-, Minnesota antilymphocyte globulin-, or an OKT3-based protocol.
Ladowski JS; Dillon T; Schatzlein MH; Peterson AC; Deschner WP; Beatty L; Sullivan M; Scheeringa RH; Clark WR
J Cardiovasc Surg (Torino); 1993 Apr; 34(2):135-40. PubMed ID: 8320247
[TBL] [Abstract][Full Text] [Related]
35. Thymoglobulin-Resistant T-Cell-Mediated Acute Rejection in a Pregnant Renal Transplant Recipient: Case Report and Review of the Literature.
Balaha M; Al-Otaibi T; Gheith OA; Halim MA; Shaker M; Fayyad Z; Nair P; Zakaria Z; Abo-Atya H; Makkeyia Y
Exp Clin Transplant; 2019 Jan; 17(Suppl 1):159-163. PubMed ID: 30777545
[TBL] [Abstract][Full Text] [Related]
36. Single-shot antithymocyte globulin (ATG) induction for pancreas/kidney transplantation: ATG-Fresenius versus Thymoglobulin.
Schulz T; Papapostolou G; Schenker P; Kapischke M
Transplant Proc; 2005 Mar; 37(2):1301-4. PubMed ID: 15848703
[TBL] [Abstract][Full Text] [Related]
37. Induction therapy including antithymocyte globulin induces marked alterations in T lymphocyte subpopulations after liver transplantation: results of a long-term study.
Oertel M; Sack U; Kohlhaw K; Lehmann I; Emmrich F; Berr F; Hauss J; Schwarz R
Transpl Int; 2002 Oct; 15(9-10):463-71. PubMed ID: 12389078
[TBL] [Abstract][Full Text] [Related]
38. Randomized controlled trial of a monoclonal antibody against the interleukin-2 receptor (33B3.1) as compared with rabbit antithymocyte globulin for prophylaxis against rejection of renal allografts.
Soulillou JP; Cantarovich D; Le Mauff B; Giral M; Robillard N; Hourmant M; Hirn M; Jacques Y
N Engl J Med; 1990 Apr; 322(17):1175-82. PubMed ID: 2157982
[TBL] [Abstract][Full Text] [Related]
39. Advantage of antithymocyte globulin induction in sensitized kidney recipients: a randomized prospective study comparing induction with and without antithymocyte globulin.
Thibaudin D; Alamartine E; de Filippis JP; Diab N; Laurent B; Berthoux F
Nephrol Dial Transplant; 1998 Mar; 13(3):711-5. PubMed ID: 9550651
[TBL] [Abstract][Full Text] [Related]
40. A single institution, randomized, prospective trial of cyclosporin versus azathioprine-antilymphocyte globulin for immunosuppression in renal allograft recipients.
Najarian JS; Fryd DS; Strand M; Canafax DM; Ascher NL; Payne WD; Simmons RL; Sutherland DE
Ann Surg; 1985 Feb; 201(2):142-57. PubMed ID: 3882063
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
